Bruce Jackson Analyst Performance

Equity Research Analyst at Benchmark

Bruce Jackson is a stock analyst at Benchmark focused in the medical sector, covering 21 publicly traded companies. Over the past year, Bruce Jackson has issued 11 stock ratings, including and buy recommendations. While full access to Bruce Jackson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Bruce Jackson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 44 Last 10 Years
Buy Recommendations: 86.36% 38 Buy Ratings
Companies Covered: 21 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	86.4%	38 ratings
Hold	13.6%	6 ratings
Sell	0.0%	0 ratings

Out of 44 total stock ratings issued by Bruce Jackson at Benchmark, the majority (86.4%) have been Buy recommendations, followed by 13.6% Hold.

Best & Worst Calls

Best Call
000.0%
FLXN
Apr 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
MDXG
Dec 2017
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	90.5% of companies on NASDAQ	19 companies
NYSE	9.5% of companies on NYSE	2 companies

Bruce Jackson, an analyst at Benchmark, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 19 companies	90.5%
	Manufacturing 1 company	4.8%
	Computer and Technology 1 company	4.8%

Bruce Jackson of Benchmark specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 8 companies	38.1%
PHARMACEUTICAL PREPARATIONS 4 companies	19.0%
MED PRODUCTS 1 company	4.8%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES 1 company	4.8%
INSTRU - SCIENTFC 1 company	4.8%
MEDICAL LABORATORIES 1 company	4.8%
MEDICAL SERVICES 1 company	4.8%
MED/DENTAL - SUPP 1 company	4.8%
MED - DRUGS 1 company	4.8%
MED INSTRUMENTS 1 company	4.8%
MEDICAL INFO SYS 1 company	4.8%

About Bruce Jackson

Bruce Jackson is an Equity Research Analyst focused on Healthcare Technology companies that improve patient outcomes while lowering the total cost of care. He’s been named a Wall Street Journal All-Star for stock picking in Health Equipment & Supplies and received the FT/StarMine Analyst Award for Number 1 stock picker in Health Care Equipment and Supplies. Bruce began his Wall Street career at Vector Securities and has held Senior analyst positions at Wachovia, RBC, and Morgan Joseph TriArtisan. Before Wall Street, he worked at Abbott Laboratories in their Hospital Products and Diagnostics Divisions. Bruce is a graduate of the University of Wisconsin, holds an MBA from the Johnson Graduate School of Management at Cornell University, and was recently awarded a Masters in Data Science from the University of St. Thomas.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ABT Abbott Laboratories	10/10/2025	Initiated Coverage	$133.24	$145.00	Buy
CV CapsoVision	7/28/2025	Initiated Coverage	$4.00	$5.00	Speculative Buy
BFRI Biofrontera	5/19/2025	Lower Price Target	$0.66	$2.75	Buy
HUMA Humacyte	5/14/2025	Lower Price Target	$1.91	$14.00	Buy
HBIO Harvard Bioscience	5/13/2025	Lower Price Target	$0.36	$3.00	Speculative Buy
CLNN Clene	5/8/2025	Lower Price Target	$2.66	$33.00	Buy
GNLX Genelux	5/8/2025	Lower Price Target	$2.49	$23.00	Speculative Buy
BLTE Belite Bio	3/26/2025	Reiterated Rating	$65.18	$80.00	Buy
HBIO Harvard Bioscience	3/24/2025	Lower Price Target	$0.65	$4.50	Speculative Buy
HUMA Humacyte	2/27/2025	Reiterated Rating	$3.74		Buy
BLTE Belite Bio	1/21/2025	Boost Price Target	$60.05	$79.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.